NCT00139581
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- This study is not being conducted in the United States Novartis Pharma AG, Basel, Switzerland
Clinical trial condition
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
NCT00139581
NCT00660322
NCT00189722
NCT00189787
NCT00550472
NCT00504946
NCT00531414
Not specified
NCT00655109
NCT00567918
NCT00195065